Merck

Develops medicines and vaccines for health issues

Kenilworth, Illinois, United States

About Merck

Merck develops medicines and vaccines to address major health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck's products include prescription medicines, vaccines, and animal health products, which are sold to patients, healthcare professionals, and institutions around the world. A key aspect of Merck's approach is its commitment to patient assistance programs that provide free medications and vaccines to those in need. Unlike many competitors, Merck also offers professional resources through platforms like Merck Connect and Merck Manuals, enhancing support for healthcare providers.

Kenilworth, IllinoisHeadquarters
1891Year Founded
$347.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Holidays
Paid Vacation
Paid Sick Leave
Hybrid Work Options
Flexible Work Hours

Risks

Competition from biosimilar companies like Alvotech may erode Merck's market share.
Collaboration with Personalis and Moderna may lead to strategic misalignments.
Investment in Ambrosia Biosciences poses risks if preclinical developments fail.

Differentiation

Merck's collaboration with Atropos Health accelerates real-world evidence generation using AI.
Merck invests in precision therapies, enhancing R&D for targeted treatments.
Merck's strategic partnerships in AI and data analytics speed up drug discovery.

Upsides

Merck's focus on personalized medicine boosts its R&D for targeted therapies.
Digital health technologies enhance Merck's patient assistance programs.
Biosimilar market expansion offers Merck opportunities to diversify its portfolio.

Funding

Total raised$347.36 M
StageIPO
GRANT
11/30/2020
$356